VIKING GLOBAL INVESTORS LP 13D and 13G filings for NewAmsterdam Pharma Company N.V.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 4:50 pm Sale |
2024-12-31 | 13G | NewAmsterdam Pharma Company N.V. NAMS |
VIKING GLOBAL INVESTORS LP | 6,978,534 6.500% |
-1,046,031 (-13.04%) |
Filing |
| 2024-02-14 10:12 am Purchase |
2023-12-31 | 13G | NewAmsterdam Pharma Company N.V. NAMS |
VIKING GLOBAL INVESTORS LP | 8,024,565 9.700% |
1,500,000 (+22.99%) |
Filing |
| 2023-06-20 4:30 pm Purchase |
2023-06-07 | 13G | NewAmsterdam Pharma Company N.V. NAMS |
VIKING GLOBAL INVESTORS LP | 6,524,565 7.980% |
6,524,565 (New Position) |
Filing |